M. Trotta

发表

Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance.

P. Narciso, A. Antinori, A. De Luca, 2003, The Journal of infectious diseases.

Timed short messaging service improves adherence and virological outcomes in HIV-1-infected patients with suboptimal adherence to antiretroviral therapy.

R. Maserati, G. d’Ettorre, A. Antinori, 2011, Journal of acquired immune deficiency syndromes.

Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy.

P. Narciso, A. Antinori, V. Tozzi, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Does depression symptomatology affect medication compliance during the first weeks of anti-HCV therapy in intravenous drug users?

A. Antinori, V. Guadagnino, M. Trotta, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

A fuzzy relational system trained by genetic algorithms and HIV-1 resistance genotypes/virological response data from prospective studies usefully predicts treatment outcomes

G. Ulivi, L. Ruiz, M. Prosperi, 2004 .

The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real‐life experience

L. Pani, U. Visco-Comandini, P. Caraceni, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: data from the Italian AIFA Anti-diabetics Monitoring Registry.

L. Pani, G. Marchesini, D. Melchiorri, 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes

L. Pani, G. Pietrosi, G. Cordone, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

Rate of CD4+ cell count increase over periods of viral load suppression: relationship with the number of previous virological failures.

A. d’Arminio Monforte, V. Vullo, A. Antinori, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A. Antinori, A. Monforte, M. Trotta, 2002, Journal of acquired immune deficiency syndromes.

Dynamics of NRTI resistance mutations during therapy interruption.

Thomas Lengauer, F. Ceccherini‐Silberstein, P. Narciso, 2009, AIDS research and human retroviruses.

Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals.

V. Vullo, A. Antinori, V. Tozzi, 2008, AIDS patient care and STDs.

Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens.

P. Narciso, A. Antinori, A. De Luca, 2003, AIDS.

Comparison of Demand for Drugs Used for COVID-19 Treatment and Other Drugs During the Early Phase of the COVID-19 Pandemic in Italy

N. Magrini, M. Trotta, A. Ammassari, 2021, JAMA network open.

, Virus Type 1 Regulatory Protein Rev Mutations in the Human Immunodeficiency Enfuvirtide Influences the Appearance of Treatment with the Fusion Inhibitor

A. Laganà, F. Ceccherini‐Silberstein, A. Ferro, 2009 .

Relative Prognostic Value of Self-Reported Adherence and Plasma Nnrti/Pi Concentrations to Predict Virological Rebound in Patients Initially Responding to Haart

D. Nauwelaers, P. Narciso, A. Antinori, 2004, Antiviral therapy.

Beyond Virological Suppression: The Role of Adherence in the Late Haart Era

A. Antinori, Noga Shalev, M. Trotta, 2012, Antiviral therapy.

HAART has increased the life expectancy of HIV-infected individuals significantly. Optimal adherence to HAART results in viral suppression and immune recovery in the majority of HIV-infected persons. Data from the early HAART

A. Antinori, Noga Shalev, M. Trotta, 2012 .

Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis

A. Gasbarrini, E. Giannini, M. Marzioni, 2018, Infection.

Promoting Better Clinical Trials and Drug Information as Public Health Interventions for the COVID-19 Emergency in Italy

N. Magrini, M. Trotta, A. Genazzani, 2020, Annals of Internal Medicine.

Using a Database of HIV Patients Undergoing Genotypic Resistance Test after Haart Failure to Understand the Dynamics of M184V Mutation

A. Antinori, V. Tozzi, P. Noto, 2003, Antiviral therapy.

Impact of metabolic complications on antiretroviral treatment adherence: Clinical and public health implications

J. Nachega, M. Nelson, M. Trotta, 2009, Current HIV/AIDS reports.

Construction, Training and Clinical Validation of An Interpretation System for Genotypic HIV-1 Drug Resistance Based on Fuzzy Rules Revised by Virological Outcomes

Marilena Vendittelli, Giovanni Ulivi, Francesco Baldini, 2003, Antiviral therapy.

Self‐Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection

A. Wu, M. Moroni, P. Narciso, 2001, Journal of acquired immune deficiency syndromes.

Depression Is a Risk Factor for Suboptimal Adherence to Highly Active Antiretroviral Therapy

A. Wu, A. Antinori, A. Monforte, 2002, Journal of acquired immune deficiency syndromes.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Virological response to Salvage Therapy in HIV-Infected Persons Carrying the Reverse Transcriptase K65R Mutation

F. Ceccherini‐Silberstein, A. Antinori, P. Lorenzini, 2007, Antiviral therapy.

Clinical and genotypic correlates of mutation K65R in HIV‐infected patients failing regimens not including tenofovir

F. Ceccherini‐Silberstein, P. Narciso, A. Antinori, 2006, Journal of medical virology.

Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors

Valentina Svicher, Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, 2005, Antimicrobial Agents and Chemotherapy.

Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients

P. Narciso, A. Antinori, V. Tozzi, 2005, AIDS.

Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.

A. Wu, A. Antinori, A. Monforte, 2004, Psychosomatics.

Relationship Between HAART Adherence and Adipose Tissue Alterations

A. Wu, A. Antinori, A. Monforte, 2002, Journal of acquired immune deficiency syndromes.

Patient-reported and physician-estimated adherence to HAART

Albert W. Wu, Rita Murri, A. Wu, 2004, Journal of General Internal Medicine.

Correlates and Predictors of Adherence to Highly Active Antiretroviral Therapy: Overview of Published Literature

A. Wu, P. Narciso, A. Antinori, 2002, Journal of acquired immune deficiency syndromes.

Role of serum free light chains in predicting HIV‐associated non‐Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy

A. d’Arminio Monforte, A. di Caro, A. Antinori, 2012, American journal of hematology.

Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort.

Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, P. Narciso, 2004, The Journal of infectious diseases.

Treatment with the Fusion Inhibitor Enfuvirtide Influences the Appearance of Mutations in the Human Immunodeficiency Virus Type 1 Regulatory Protein Rev

A. Laganà, F. Ceccherini‐Silberstein, A. Ferro, 2009, Antimicrobial Agents and Chemotherapy.

The Effect of Number of Mutations and of Drug-Class Sparing on Virological Response to Salvage Genotype-Guided Antiretroviral Therapy

P. Narciso, A. Antinori, V. Tozzi, 2002, Antiviral therapy.

Sexual dysfunction in HIV infection

A. Antinori, A. Monforte, M. Trotta, 2007, The Lancet.

Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine.

L. Ruiz, M. Prosperi, A. Antinori, 2007, The Journal of infectious diseases.

Antiviral Efficacy and Genotypic Resistance Patterns of Combination Therapy with Stavudine/Tenofovir in Highly Active Antiretroviral Therapy Experienced Patients

Stefano Bonora, Stefania Merli, Massimo Andreoni, 2006, Antiviral therapy.

AVT-882 Antinori

A. Antinori, V. Tozzi, M. Andreoni, 2006 .

Virologic Correlates of Adherence to Antiretroviral Medications and Therapeutic Failure

F. Ceccherini‐Silberstein, V. Vullo, A. Antinori, 2002, Journal of acquired immune deficiency syndromes.

Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure.

Andrea De Luca, P. Narciso, A. Antinori, 2002, AIDS research and human retroviruses.

Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy.

C. Perno, A. De Luca, A. Cingolani, 2001, AIDS.

The V118I Mutation as a Marker of Advanced HIV Infection and Disease Progression

F. Ceccherini‐Silberstein, P. Narciso, A. Antinori, 2007, Antiviral therapy.

Effectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes.

A. Antinori, S. Babudieri, R. Monarca, 2007, Addiction.

Drug-Class-Wide Resistance to Antiretrovirals in HIV-Infected Patients Failing Therapy: Prevalence, Risk Factors and Virological Outcome

P. Narciso, A. Antinori, V. Tozzi, 2005, Antiviral therapy.

High incidence of tuberculin skin test conversion among HIV-infected individuals who have a favourable immunological response to highly active antiretroviral therapy.

P. Narciso, G. Ippolito, A. Antinori, 2002, AIDS (London).

Temporal characterization of drug resistance associated mutations in HIV-1 protease and reverse transcriptase in patients failing antiretroviral therapy.

F. Ceccherini‐Silberstein, P. Narciso, A. Antinori, 2006, The new microbiologica.

Historical resistance profile helps to predict salvage failure

Francesca Ceccherini-Silberstein, F. Ceccherini‐Silberstein, P. Narciso, 2009, Antiviral therapy.

Historical resistance profile helps to predict salvage failure

F. Ceccherini‐Silberstein, P. Narciso, A. Antinori, 2009, Antiviral therapy.

Lipodystrophy is associated with a low rate of treatment failure in HIV-positive patients switched to atazanavir.

A. Antinori, M. Trotta, G. Liuzzi, 2005, Journal of acquired immune deficiency syndromes.